Prostate Cancer
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.
October 5, 2023
Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy.
October 5, 2023
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
October 5, 2023
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
October 5, 2023
Pilot Study of a Novel Ring Gantry-Based PET/CT Linear Accelerator in Patients with Prostate Cancer Receiving [18F]-DCFPyL for PSMA PET Imaging.
October 4, 2023
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
October 4, 2023
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies
October 3, 2023
Predicting 18F-DCFPyL-PET/CT Scan Positivity in Prostate Cancer Patients with Biochemical Recurrence.
October 3, 2023
Active surveillance should be considered for select men with Grade Group 2 prostate cancer.
October 3, 2023
Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-Analysis of Prospective Studies.
October 3, 2023
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer.
October 3, 2023